Definium Therapeutics offers 18,375,000 common shares
Securities offering
- Form
- 424B5
- Filed
- Importance
- Routine
- Accession
- 0001104659-25-104545
- Offering 18,375,000 common shares at $12.25 per share
- Public offering price total of $225,093,750
- Proceeds to company before expenses of $211,588,125
- Underwriters have option to buy additional 2,756,250 shares
Written from the 424B5 on EDGAR. Check the filing before you rely on it.
Similar companies
Companies of similar size in SIC 2833 and related industry codes: the same peer list as the financial tables.
- Myriad Genetics MYGN public float $494M, Jun 30, 2025
- Kura Oncology KURA public float $496M, Jun 30, 2025
- KalVista Pharmaceuticals KALV public float $499M, Jun 30, 2025
- Arbutus Biopharma ABUS public float $472M, Jun 30, 2025
- Arvinas ARVN public float $469M, Jun 30, 2025
